SOUTH ORANGE, NJ, Sept. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products to the medical device and commercial markets, today announced presentations at five upcoming investor conferences.
Daron Evans, President and Chief Executive Officer, and Andy Astor, Chief Operating and Financial Officer, will provide overviews of Nephros’ business during the conferences and will be available for one-on-one meetings with registered participants. Company information, including the most recent corporate presentation, is available on the Nephros website: https://www.nephros.com/investor-relations/
LD Micro San Francisco SummitDate: Tuesday, September 3Time: 8:40am Pacific TimeLocation: JW Marriott, San FranciscoSpeaker: Daron EvansFor more information: https://www.ldmicro.com
RHK Capital 2019 Disruptive Growth ConferenceDate: Wednesday, September 4Time: 2:40pm Eastern TimeLocation: Reed Smith, New York, NYSpeaker: Andy AstorFor more information and webcast: http://disruptnyc.com
Fall Investor SummitDate: Monday, September 16Time: 9:00am Eastern TimeLocation: The Essex House, New York, NYSpeaker: Andy AstorFor more information: https://microcapconf.com
MicroCap Leadership SummitDate: Friday, September 27, 2019Time: All dayLocation: Westin Chicago Northwest Hotel, Itasca, IllinoisSpeaker: Andy Astor
For more information: https://microcapclub.com/summit/
LD Micro New York City SummitDate: Monday, October 7, 2019Time: 9:00am Eastern TimeLocation: Lowenstein Sandler, 1251 6th Ave., New York, NYSpeaker: Andy AstorFor more information: https://www.ldmicro.com/events
About Nephros, Inc.
Nephros is a commercial stage company that develops and sells high performance water purification products to the medical device and commercial markets. Nephros ultrafilters are used in hospitals and medical clinics for added protection in retaining bacteria (e.g., Legionella, Pseudomonas) and viruses from water, providing barriers that assist in improving infection control in showers, sinks, and ice machines. Additionally, Nephros ultrafilters are used by dialysis centers for assisting in the added removal of endotoxins and other biological contaminants from the water and bicarbonate concentrate supplied to hemodialysis machines and patients.
Nephros filters, including AETHER™ brand filters, improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Nephros and AETHER™ products are used in the health care, food service, hospitality, and convenience store markets.
For more information about Nephros, please visit our website at www.nephros.com.
Investor Relations Contact: Kirin Smith, President PCG Advisory, Inc. (646) 863-6519 firstname.lastname@example.org